BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31535950)

  • 1. Prognostic factors in pediatric Hodgkin lymphoma: experience from a developing country.
    Ghafoor T
    Leuk Lymphoma; 2020 Feb; 61(2):344-350. PubMed ID: 31535950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and Prognostic analysis of 43 Children with Mature B-cell Non-Hodgkin's Lymphoma/Acute Lymphoblastic Leukemia].
    Guo J; Zhu YP; Gao J; Li Q; Jia CS; Zhou CY; Guo X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Feb; 24(1):72-9. PubMed ID: 26913397
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictors of treatment outcome of Wilms Tumour in low-income country; single centre experience from Pakistan.
    Ghafoor T; Bashir F; Ahmed S; Khalil S; Farah T
    J Pediatr Urol; 2020 Jun; 16(3):375.e1-375.e7. PubMed ID: 32224063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A analysis of the outcome and prognostic factors in 415 patients with Hodgkin lymphoma].
    Tao Y; Kang S; Zhou L; Shi Y; Li Y; Sun Y
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):466-71. PubMed ID: 26463153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment results and prognostic significance of selected clinical and laboratory features in children diagnosed with malignant lymphoma].
    Kamieńska E
    Ann Acad Med Stetin; 1996; 42():105-22. PubMed ID: 9199116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hodgkin lymphoma in children: experience in a tertiary care centre in India.
    Trehan A; Singla S; Marwaha RK; Bansal D; Srinivasan R
    J Pediatr Hematol Oncol; 2013 Apr; 35(3):174-9. PubMed ID: 23073046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk factors predicting outcomes for primary refractory hodgkin lymphoma patients treated with salvage chemotherapy and autologous stem cell transplantation.
    Shah GL; Yahalom J; Matasar MJ; Verwys SL; Goldman DA; Bantilan KS; Zhang Z; McCall SJ; Moskowitz AJ; Moskowitz CH
    Br J Haematol; 2016 Nov; 175(3):440-447. PubMed ID: 27377168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.
    Abdelhamid T; Samra M; Ramadan H; Mehessin M; Mokhtar N
    J Egypt Natl Canc Inst; 2011 Mar; 23(1):17-24. PubMed ID: 22099932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lymphoblastic lymphoma of childhood and the LSA2-L2 protocol: the 30-year experience at Memorial-Sloan-Kettering Cancer Center.
    Mora J; Filippa DA; Qin J; Wollner N
    Cancer; 2003 Sep; 98(6):1283-91. PubMed ID: 12973853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adolescents and young adults with classical Hodgkin lymphoma in northern Tunisia: insights from an adult single-institutional study.
    Zawati I; Adouni O; Finetti P; Manai M; Manai M; Gamoudi A; Birnbaum D; Bertucci F; Mezlini A
    Cancer Radiother; 2020 Jun; 24(3):206-214. PubMed ID: 32171674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Hodgkin lymphoma in children: a 20-year population-based epidemiologic study in western Sweden.
    Samuelsson BO; Ridell B; Röckert L; Gustafsson G; Márky I
    J Pediatr Hematol Oncol; 1999; 21(2):103-10. PubMed ID: 10206455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Salvage chemotherapy with mitoxantrone, fludarabine, cytarabine, and cisplatin (MIFAP) in relapsing and refractory lymphoma.
    Hänel M; Kröger N; Kroschinsky F; Birkmann J; Hänel A; Herbst R; Naumann R; Friedrichsen K; Ehninger G; Zander AR; Fiedler F
    J Cancer Res Clin Oncol; 2001; 127(6):387-95. PubMed ID: 11414199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-based combined-modality therapy of pediatric Hodgkin's lymphoma: a retrospective study.
    Ali A; Sayed H; Farrag A; El-Sayed M
    Leuk Res; 2010 Nov; 34(11):1447-52. PubMed ID: 20599270
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pediatric Hodgkin disease in North Tunisia: clinical and therapeutic study].
    Kochbati L; Fdhila F; Belaid I; Rifi H; Barsaoui S; Ben Romdhane N; Bel Hadj Ali Z; Mezlini A; Oubich F; Maalej M
    Cancer Radiother; 2012 Oct; 16(7):627-32. PubMed ID: 23084987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.
    Pinnix CC; Osborne EM; Chihara D; Lai P; Zhou S; Ramirez MM; Oki Y; Hagemeister FB; Rodriguez AM; Samaniego F; Fowler N; Romaguera JE; Turturro F; Fayad L; Westin JR; Nastoupil L; Neelapu SS; Cheah CY; Dabaja BS; Milgrom SA; Smith GL; Horace P; Milbourne A; Wogan CF; Ballas L; Fanale MA
    JAMA Oncol; 2016 Aug; 2(8):1065-9. PubMed ID: 27227654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome and Prognostic Factors of Childhood Hodgkin Disease: Experience From a Single Tertiary Center in Thailand.
    Chotsampancharoen T; Chavananon S; Sripornsawan P; Duangchu S; McNeil E
    J Pediatr Hematol Oncol; 2021 Jan; 43(1):e85-e89. PubMed ID: 32590417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary refractory Hodgkin's lymphoma: outcome after high-dose chemotherapy and autologous SCT and impact of various prognostic factors on overall and event-free survival. A single institution result of 66 patients.
    Akhtar S; El Weshi A; Abdelsalam M; Hussaini H; Janabi I; Rahal M; Maghfoor I
    Bone Marrow Transplant; 2007 Oct; 40(7):651-8. PubMed ID: 17660837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the prognosis of pediatric Hodgkin lymphoma in developing countries: a Moroccan Society of Pediatric Hematology and Oncology study.
    Hessissen L; Khtar R; Madani A; El Kababri M; Kili A; Harif M; Khattab M; Sahraoui S; Benjaafar N; Ahid S; Howard SC; Benchekroun S
    Pediatr Blood Cancer; 2013 Sep; 60(9):1464-9. PubMed ID: 23606223
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The International Prognostic Index predicts outcome after histological transformation of low-grade non-Hodgkin lymphoma.
    Micallef IN; Remstein ED; Ansell SM; Colgan JP; Inwards DJ; Johnston PB; Lewis JT; Markovic SN; Porrata LF; White WL; Witzig TE; Ristow K; Habermann TM
    Leuk Lymphoma; 2006 Sep; 47(9):1794-9. PubMed ID: 17064990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Feasibility study of application of international prognostic score on prediction of prognosis for advanced Hodgkin's lymphoma].
    Fu XH; Wang SS; Huang Y; Wang B; Huang HQ; Zhang L; Sun XF; Xu RH; Lin TY
    Ai Zheng; 2006 Aug; 25(8):1013-8. PubMed ID: 16965685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.